Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
histiocytoma/nausée
Le lien est enregistré dans le presse-papiers
Page 1 de 17 résultats
[A case of malignant fibrous histiocytoma treated with intraarterial chemotherapy under complete venous isolation and charcoal hemoperfusion].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Herein reported is a case with malignant fibrous histiocytoma (MFH) at the left elbow treated successfully with intraarterial chemotherapy under complete brachial venous isolation and charcoal hemoperfusion (BVI-CHP). A 56-year-old man was admitted to our institution because of local recurrence at
Benign fibrous histiocytoma of the stomach: report of a case.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
We report herein an extremely very rare case of primary benign fibrous histiocytoma of the stomach found in a 56-year-old man who presented with a 2-week history of nausea and anorexia. Gastrointestinal X-rays and endoscopy revealed a protruding lesion in the stomach, but biopsies failed to
Brain metastasis from malignant fibrous histiocytoma of the heart: case report.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This is the second reported case of a malignant fibrous histiocytoma of the heart that metastasized to the brain. A 33-year-old woman developed headache, nausea, and ataxic gait 9 months after removal of the tumor from the left atrium of the heart. Computed tomographic and magnetic resonance imaging
A primary malignant fibrous histiocytoma of the scalp and intracranial tumor bleeding: a case report.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND
A malignant fibrous histiocytoma occurring on the scalp near a primary operation site is extremely rare.
METHODS
A 74-year-old Chinese man presented with a one-month history of recurrent headaches, vomiting and left limb atony. He had undergone a successful clipping operation through the
[Combination chemotherapy with vincristin, actinomycin D, cyclophosphamide and adriamycin in soft-part sarcoma].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Fifteen patients with soft-part sarcoma were treated with combination chemotherapy consisting of vincristin, actinomycin D, cyclophosphamide and adriamycin (VACA therapy). The cumulative five-year survival rate by the Kaplan-Meier method was about 73%. This VACA therapy was effective for malignant
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
One-hundred-fourteen evaluable patients with metastatic soft tissue or bony sarcoma with measurable disease were treated with Adriamycin (doxorubicin) administered intravenously at a dose of 60 mg/M2 on day 1, followed by DTIC (dacarbazine) at a dose of 750 mg/M2; courses were administered at 3-week
[The clinical phase I study of TNP-351. The TNP-351 Research Committee].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The clinical phase I study of TNP-351, an antifolate drug having a novel structure, was performed through a multicenter cooperative program in 40 patients with solid tumors. The test drug was used on dosage schedules of single and daily doses for 5 or 3 days (by intravenous drip over 30 minutes,
[Two cases of the middle fossa tumor following radiotherapy against retinoblastoma].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Two cases of brain tumors which developed after radiotherapy against retinoblastomas are reported. A 17-year-old girl was admitted with a chief complaint of swelling in her forehead after head injury in July, 1981. At 7 months old her left eye had been enucleated and she had received radiation
A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U).
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Thirty-eight patients with advanced resistant cancers were enrolled on this study of piritrexim (PTX; BW 301U) administered intravenously weekly for 4 weeks. Of 50 courses of treatment begun, 39 evaluable 4-week courses of the drug were completed by this group of patients. Dosages ranged from 44 to
Human pharmacological investigation of a human recombinant tumor necrosis factor preparation (PAC-4D) a phase-I trial.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
15 patients aged between 24 and 66 years with 10 different malignant tumor diseases were treated with a recombinant human tumor necrosis factor preparation PAC-4D in a phase-I trial. The starting dose was 10(5) U PAC-4D as an intravenous short infusion. The maximally tolerable dose is around 18 X
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Methods
In this retrospective, multicenter (6 centers), observational study, we analyzed the medical charts ofA phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Thirty-two patients with advanced, inoperable nonhematologic soft-tissue and osseous sarcomas were treated with Methyl CCNU administered via controlled intravenous infusion in doses of 130-170 mg/m2 every 6 weeks in a Phase II trial. All 28 evaluable patients were no longer responsive to adriamycin.
EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS).Subjects. Twenty-seven patients with progressive and measurable disease were treated. Median age was 53 years (range 20-71
[Primary retroperitoneal tumors. Our experience].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Primary retroperitoneal tumors are rare (0.05-0.2% of all tumors), often malignant and characterized by a poor and non-specific symptomatology and by a late diagnosis. Complete resection is possible in only a few patients, while recurrence is very common. The records of 29 adult patients who
Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomas.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Twenty previously treated patients with advanced bone sarcomas received thrice weekly im 50 X 10(6) IU/m2 doses of human alfa-interferon (interferon alfa-2a, recombinant; Roche). Seventeen patients had metastatic osteosarcomas and one each had fibrosarcoma, mesenchymal chondrosarcoma, and malignant
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
